PROCEPT BioRobotics(PRCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PRCT PROCEPT BioRobotics

Pre-Mkt 12-16 08:15:29 EST

36.10

+0.11

+0.31%

盘前35.79

-0.31-0.86%

08:01 EST

High36.90	Low35.37	Vol1.25M
Open36.23	D1 Closing35.99	Amplitude4.25%
Mkt Cap2.02B	Tradable Cap1.93B	Total Shares55.88M
T/O44.94M	T/O Rate2.32%	Tradable Shares53.56M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PRCT","market":"US","secType":"STK","nameCN":"PROCEPT BioRobotics","latestPrice":36.1,"timestamp":1765832400000,"preClose":35.99,"halted":0,"volume":1245315,"hourTrading":{"tag":"盘前","latestPrice":35.79,"preClose":36.1,"latestTime":"08:01 EST","volume":142,"amount":5123.14842,"timestamp":1765890060551},"delay":0,"floatShares":53564164,"shares":55878589,"eps":-1.538236,"marketStatus":"Pre-Mkt","change":0.11,"latestTime":"12-16 08:15:29 EST","open":36.23,"high":36.9,"low":35.37,"amount":44936594.0238,"amplitude":0.042512,"askPrice":36.3,"askSize":100,"bidPrice":35,"bidSize":21,"shortable":3,"etf":0,"ttmEps":-1.538236,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1765895400000},"marketStatusCode":1,"adr":0,"listingDate":1631678400000,"exchange":"NASDAQ","adjPreClose":36.1,"preHourTrading":{"tag":"盘前","latestPrice":35.79,"preClose":36.1,"latestTime":"08:01 EST","volume":142,"amount":5123.14842,"timestamp":1765890060551},"postHourTrading":{"tag":"盘后","latestPrice":36.1,"preClose":36.1,"latestTime":"19:54 EST","volume":18433,"amount":665367.278,"timestamp":1765846443629},"volumeRatio":0.7829362074447483,"impliedVol":0.5706,"impliedVolPercentile":0.3012},"requestUrl":"/m/hq/s/PRCT/wiki","defaultTab":"wiki","newsList":[{"id":"2591688684","title":"PROCEPT BioRobotics Initiated at Buy by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2591688684","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591688684?lang=en_us&edition=fundamental","pubTime":"2025-12-13 00:22","pubTimestamp":1765556520,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRCT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 12, 2025 11:22 ET (16:22 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRCT","BK4082","LU2324357040.USD"],"gpt_icon":0},{"id":"2590236880","title":"Sector Update: Health Care Stocks Lower in Afternoon Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2590236880","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590236880?lang=en_us&edition=fundamental","pubTime":"2025-12-09 02:43","pubTimestamp":1765219408,"startTime":"0","endTime":"0","summary":"Health care stocks declined Monday afternoon, with the NYSE Health Care Index down 1% and the Health Care Select Sector SPDR Fund  falling 1%.The iShares Biotechnology ETF  decreased 0.6%.In corporate news, STAAR Surgical  shares fell 4% after the company said Monday the go-shop period under its merger agreement with Alcon  has expired with no competing proposals received. Alcon was down 1.9%.PROCEPT BioRobotics  still has a large market opportunity for its aquablation technology to treat benign prostatic hyperplasia, but utilization growth has slowed, BofA Securities said in a research report. The brokerage downgraded the stock to neutral from buy and lowered its price target to $38 per share from $55. PROCEPT shares dropped 4.8%.Wave Life Sciences  shares soared 129% after the company said interim data from its phase 1 trial of WVE-007 to treat obesity showed improvements in body composition, with weight loss similar to GLP-1, but without muscle loss, at three months compared to base","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XLV","LU1804176565.USD","BK4548","IBB","BK4599","BK4585","BK4007","ALC","BK4581","PRCT","BK4082","BK4588","STAA","LU2324357040.USD","BK4534","GPCR","LABU","BK7094","BK4198","WVE","LU2265009873.SGD","XBI","ALC.AU"],"gpt_icon":0},{"id":"2590035228","title":"PROCEPT BioRobotics has Large Market Opportunity, but Utilization Growth has Slowed, BofA Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2590035228","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590035228?lang=en_us&edition=fundamental","pubTime":"2025-12-09 00:37","pubTimestamp":1765211876,"startTime":"0","endTime":"0","summary":"PROCEPT BioRobotics  still has a large market opportunity for its aquablation technology to treat benign prostatic hyperplasia, but utilization growth has slowed, BofA Securities said in a Monday research report.The company could achieve operating profitability in 2029, given it records a 20% revenue compound annual growth rate and gross margin of 60%, analysts wrote.BofA's survey of urologists indicated moderate incremental market share capture for aquablation in BPH treatment, with maximum penetration expected at 23%. Limiting factors included prostate size, financial considerations, bleeding risks, and other treatments, according to the report.The survey suggests aquablation procedure growth of 26% in 2026, 19% in 2027, and 18% in 2028. However, the brokerage stated that there are limitations to this analysis, as the survey may not represent the overall market.The brokerage said it downgraded the stock to neutral from buy and lowered its price target to $38 per share from $55.Price:","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","LU2324357040.USD","PRCT"],"gpt_icon":0},{"id":"2589720359","title":"Procept Biorobotics Corp : Bofa Global Research Cuts to Neutral From Buy; Cuts Price Objective to $38 From $55","url":"https://stock-news.laohu8.com/highlight/detail?id=2589720359","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589720359?lang=en_us&edition=fundamental","pubTime":"2025-12-08 22:38","pubTimestamp":1765204707,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nFWN3XE0RG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","BK4082","PRCT"],"gpt_icon":0},{"id":"2589338355","title":"PROCEPT BioRobotics Cut to Neutral From Buy by B of A Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2589338355","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589338355?lang=en_us&edition=fundamental","pubTime":"2025-12-08 21:25","pubTimestamp":1765200300,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRCT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 08, 2025 08:25 ET (13:25 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRCT"],"gpt_icon":0},{"id":"2588068590","title":"PROCEPT BioRobotics Is Maintained at Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2588068590","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588068590?lang=en_us&edition=fundamental","pubTime":"2025-12-03 02:02","pubTimestamp":1764698520,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRCT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 02, 2025 13:02 ET (18:02 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRCT"],"gpt_icon":0},{"id":"2585716830","title":"PROCEPT BioRobotics® to Present at Upcoming 37th Annual Piper Sandler  Healthcare Conference on December 2, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2585716830","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585716830?lang=en_us&edition=fundamental","pubTime":"2025-11-21 05:03","pubTimestamp":1763672580,"startTime":"0","endTime":"0","summary":"SAN JOSE, Calif., Nov.  20, 2025  (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative sol","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/20/3192372/0/en/PROCEPT-BioRobotics-to-Present-at-Upcoming-37th-Annual-Piper-Sandler-Healthcare-Conference-on-December-2-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRCT","BK4137","BK4588","BK4585","LU0029874061.USD","LU0128526141.USD","XLV","HCSG","LABU","LU2324357040.USD","XBI","BK4581","BK4082"],"gpt_icon":0},{"id":"2582385030","title":"Procept Biorobotics Showcases Aquablation Therapy as Next-Generation BPH Solution in Investor Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2582385030","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582385030?lang=en_us&edition=fundamental","pubTime":"2025-11-11 06:23","pubTimestamp":1762813398,"startTime":"0","endTime":"0","summary":"Procept Biorobotics Corporation has released a new investor presentation highlighting the company's position in the benign prostatic hyperplasia  treatment market. The presentation outlines Aquablation Therapy as a unique, automated waterjet solution designed to address a wide range of prostate sizes and shapes, aiming to minimize the trade-off between safety and efficacy found in other surgical interventions. The company identifies a significant unmet need in the BPH market, noting over 8 million patients actively treated and an annual U.S. surgical market opportunity exceeding $20 billion. The presentation also discusses limitations of pharmaceutical therapies, citing minimal symptom relief and potential side effects such as ejaculatory dysfunction, erectile dysfunction, and increased risk of cardiac failure and dementia with long-term use. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative arti","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL4LW158:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LU2324357040.USD","PRCT"],"gpt_icon":0},{"id":"2581729587","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: PROCEPT BioRobotics (PRCT), Day One Biopharmaceuticals (DAWN) and Exelixis (EXEL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2581729587","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581729587?lang=en_us&edition=fundamental","pubTime":"2025-11-06 00:30","pubTimestamp":1762360240,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on PROCEPT BioRobotics (PRCT – Research Report), Day ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-procept-biorobotics-prct-day-one-biopharmaceuticals-dawn-and-exelixis-exel-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-procept-biorobotics-prct-day-one-biopharmaceuticals-dawn-and-exelixis-exel-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EXEL","BK4139","XBI","BK4539","DAWN","BK4532","BK4585","BK4082","BK4137","HCSG","BK4588","LU0029874061.USD","LU0128526141.USD","LU2324357040.USD","LABU","XLV","BK4581","PRCT"],"gpt_icon":0},{"id":"2581774526","title":"PROCEPT BioRobotics Price Target Cut to $50.00/Share From $55.00 by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2581774526","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581774526?lang=en_us&edition=fundamental","pubTime":"2025-11-06 00:01","pubTimestamp":1762358460,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRCT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 05, 2025 11:01 ET (16:01 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRCT"],"gpt_icon":0},{"id":"1129007384","title":"Stock Track | PROCEPT BioRobotics Plummets 7.71% as 2026 Revenue Guidance Disappoints Despite Q3 Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=1129007384","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129007384?lang=en_us&edition=fundamental","pubTime":"2025-11-05 23:51","pubTimestamp":1762357875,"startTime":"0","endTime":"0","summary":"Shares of PROCEPT BioRobotics (NASDAQ: PRCT) plummeted 7.71% in intraday trading on Wednesday, as investors reacted negatively to the company's 2026 revenue guidance despite better-than-expected...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PRCT"],"gpt_icon":0},{"id":"2581711377","title":"PROCEPT BioRobotics Is Maintained at Overweight by Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2581711377","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581711377?lang=en_us&edition=fundamental","pubTime":"2025-11-05 23:36","pubTimestamp":1762356960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRCT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 05, 2025 10:36 ET (15:36 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRCT"],"gpt_icon":0},{"id":"2581793877","title":"Procept Biorobotics Corp : Morgan Stanley Cuts Target Price to $56 From $62","url":"https://stock-news.laohu8.com/highlight/detail?id=2581793877","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581793877?lang=en_us&edition=fundamental","pubTime":"2025-11-05 22:53","pubTimestamp":1762354432,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nFWN3WH27M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","PRCT","LU2324357040.USD"],"gpt_icon":0},{"id":"1123493218","title":"Stock Track | PROCEPT BioRobotics Plunges 5.20% Pre-market as 2026 Revenue Guidance Disappoints Despite Q3 Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=1123493218","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123493218?lang=en_us&edition=fundamental","pubTime":"2025-11-05 21:04","pubTimestamp":1762347849,"startTime":"0","endTime":"0","summary":"Shares of PROCEPT BioRobotics (NASDAQ: PRCT) are set to open sharply lower on Wednesday, plummeting 5.20% in pre-market trading. The decline comes in the wake of the surgical robotics company's...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PRCT"],"gpt_icon":0},{"id":"1183806499","title":"Stock Track | PROCEPT BioRobotics Plunges 5.20% Pre-Market on Disappointing 2026 Revenue Guidance Despite Q3 Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=1183806499","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183806499?lang=en_us&edition=fundamental","pubTime":"2025-11-05 21:03","pubTimestamp":1762347833,"startTime":"0","endTime":"0","summary":"Shares of PROCEPT BioRobotics (NASDAQ: PRCT) tumbled 5.20% in pre-market trading on Wednesday, following the release of the company's third-quarter earnings report and 2026 revenue guidance. The...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PRCT"],"gpt_icon":0},{"id":"2581772193","title":"PROCEPT BioRobotics (PRCT): Valuation Insights Following Strong Sales Growth and Upbeat 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2581772193","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581772193?lang=en_us&edition=fundamental","pubTime":"2025-11-05 19:36","pubTimestamp":1762342562,"startTime":"0","endTime":"0","summary":"PROCEPT BioRobotics reported strong year-over-year sales growth for the third quarter and the first nine months of 2025. The company also reaffirmed its revenue targets and provided upbeat projections for the coming year, fueling fresh investor attention.\nSee our latest analysis for PROCEPT BioRobotics.\nEven with the company's robust sales growth and upbeat revenue targets, momentum has not yet translated into the stock’s performance. PROCEPT BioRobotics’ recent 1-day share price return was...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prct/procept-biorobotics/news/procept-biorobotics-prct-valuation-insights-following-strong","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prct/procept-biorobotics/news/procept-biorobotics-prct-valuation-insights-following-strong","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PRCT"],"gpt_icon":0},{"id":"2581672544","title":"Procept Biorobotics Corporation : Wells Fargo Cuts Target Price to $51 From $58","url":"https://stock-news.laohu8.com/highlight/detail?id=2581672544","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581672544?lang=en_us&edition=fundamental","pubTime":"2025-11-05 19:29","pubTimestamp":1762342150,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nAZN4QKHZJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRCT","BK4082","LU2324357040.USD"],"gpt_icon":0},{"id":"2581572590","title":"Procept Biorobotics Corp : Leerink Partners Cuts Target Price to $55 From $65","url":"https://stock-news.laohu8.com/highlight/detail?id=2581572590","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581572590?lang=en_us&edition=fundamental","pubTime":"2025-11-05 19:22","pubTimestamp":1762341779,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nFWN3WH1JV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","PRCT","BK4082"],"gpt_icon":0},{"id":"2581911725","title":"PROCEPT BioRobotics: Hold Rating Amid Strong Revenue but Concerns Over Utilization and Sales Cycles","url":"https://stock-news.laohu8.com/highlight/detail?id=2581911725","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581911725?lang=en_us&edition=fundamental","pubTime":"2025-11-05 19:07","pubTimestamp":1762340865,"startTime":"0","endTime":"0","summary":"BTIG analyst Ryan Zimmerman has maintained their neutral stance on PRCT stock, giving a Hold rating on October 24. Ryan Zimmerman has given his Hol...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/procept-biorobotics-hold-rating-amid-strong-revenue-but-concerns-over-utilization-and-sales-cycles-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/procept-biorobotics-hold-rating-amid-strong-revenue-but-concerns-over-utilization-and-sales-cycles-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRCT"],"gpt_icon":0},{"id":"2581745320","title":"U.S. RESEARCH ROUNDUP-ADM, Pinterest, UL Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2581745320","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581745320?lang=en_us&edition=fundamental","pubTime":"2025-11-05 15:39","pubTimestamp":1762328353,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-ADM, Pinterest, UL SolutionsNov 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including ADM, Pinterest a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nL4N3WH0M4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSIC","LU2720916845.USD","CDW","KYMR","FLYW","IT","SG9999003800.SGD","PTCT","AMH","GPN","LU1852331112.SGD","LU0868494617.USD","ADM","LDOS","ABBV","MIRM","CAVA","PCTY","BK4011","PRCT","MLM","LU0310800379.SGD","CAT","NMIH","EXEL","LU1983299246.USD","LU2517655291.USD","LU2089283258.USD","MASI","PINS","IE0004445239.USD","MAR","MRCY","DAVE","HLIO","HNGE","CBLL","IAC","LITE","MD","ORA","QLYS","PRIM","OCUL","IE0002270589.USD","IE00B19Z3581.USD","TAP","EXPD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.procept-biorobotics.com","stockEarnings":[{"period":"1week","weight":0.0608},{"period":"1month","weight":0.2159},{"period":"3month","weight":-0.0877},{"period":"6month","weight":-0.3949},{"period":"1year","weight":-0.5955},{"period":"ytd","weight":-0.5517}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.1394},{"period":"1year","weight":0.1266},{"period":"ytd","weight":0.1615}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.079336},{"month":2,"riseRate":0.5,"avgChangeRate":0.06046},{"month":3,"riseRate":0.5,"avgChangeRate":0.021727},{"month":4,"riseRate":0.75,"avgChangeRate":0.021233},{"month":5,"riseRate":1,"avgChangeRate":0.132144},{"month":6,"riseRate":0.25,"avgChangeRate":-0.048608},{"month":7,"riseRate":0.5,"avgChangeRate":0.00614},{"month":8,"riseRate":0.5,"avgChangeRate":0.030761},{"month":9,"riseRate":0.5,"avgChangeRate":-0.027813},{"month":10,"riseRate":0.6,"avgChangeRate":0.021826},{"month":11,"riseRate":0.4,"avgChangeRate":0.016944},{"month":12,"riseRate":0.4,"avgChangeRate":-0.030559}],"exchange":"NASDAQ","name":"PROCEPT BioRobotics","nameEN":"PROCEPT BioRobotics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"PROCEPT BioRobotics(PRCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest PROCEPT BioRobotics(PRCT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"PROCEPT BioRobotics,PRCT,PROCEPT BioRobotics股票,PROCEPT BioRobotics股票老虎,PROCEPT BioRobotics股票老虎国际,PROCEPT BioRobotics行情,PROCEPT BioRobotics股票行情,PROCEPT BioRobotics股价,PROCEPT BioRobotics股市,PROCEPT BioRobotics股票价格,PROCEPT BioRobotics股票交易,PROCEPT BioRobotics股票购买,PROCEPT BioRobotics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"PROCEPT BioRobotics(PRCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest PROCEPT BioRobotics(PRCT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}